Korean Circ J.  2011 Aug;41(8):431-433. 10.4070/kcj.2011.41.8.431.

Large Circular Ring Catheter Ablation Versus Anatomically Guided Ablation of Atrial Fibrillation: Back to the Future for Successful Catheter Ablation of Atrial Fibrillation?

• Pak HN

• KMID: 1826348
• DOI: http://doi.org/10.4070/kcj.2011.41.8.431

Abstract

No abstract available.

MeSH Terms

Catheter Ablation
Catheters

Reference

1. Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005. 293:2634–2640.

2. Jaïs P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008. 118:2498–2505.

3. Nair GM, Nery PB, Diwakaramenon S, Healey JS, Connolly SJ, Morillo CA. A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2009. 20:138–144.

4. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010. 31:2369–2429.

5. Haïssaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998. 339:659–666.

6. Perez-Lugones A, McMahon JT, Ratliff NB, et al. Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2003. 14:803–809.

7. Pak HN, Hwang C, Lim HE, Kim JW, Lee HS, Kim YH. Electroanatomic characteristics of atrial premature beats triggering atrial fibrillation in patients with persistent versus paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2006. 17:818–824.

8. Tada H, Oral H, Greenstein R, et al. Differentiation of atrial and pulmonary vein potentials recorded circumferentially within pulmonary veins. J Cardiovasc Electrophysiol. 2002. 13:118–123.

9. Oral H, Scharf C, Chugh A, et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation. 2003. 108:2355–2360.

10. Pak HN, Kim JS, Shin SY, et al. Is empirical four pulmonary vein isolation necessary for focally triggered paroxysmal atrial fibrillation? Comparison of selective pulmonary vein isolation versus empirical four pulmonary vein isolation. J Cardiovasc Electrophysiol. 2008. 19:473–479.

11. Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation. 2000. 102:2619–2628.

12. Haïssaguerre M, Hocini M, Sanders P, et al. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol. 2005. 16:1138–1147.

13. Oral H, Pappone C, Chugh A, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med. 2006. 354:934–941.

14. Everett TH 4th, Wilson EE, Olgin JE. Effects of atrial fibrillation substrate and spatiotemporal organization on atrial defibrillation thresholds. Heart Rhythm. 2007. 4:1048–1056.

15. West TC, Landa JF. Minimal mass required for induction of a sustained arrhythmia in isolated atrial segments. Am J Physiol. 1962. 202:232–236.

16. Jang SW, Shin WS, Kim JH, et al. The feasibility and efficacy of large-seized Lasso catheter combined with 3 dimensional mapping system for catheter ablation of atrial fibrillation. Korean Circ J. 2011. 41:447–452.

17. Scharf C, Boersma L, Davies W, et al. Ablation of persistent atrial fibrillation using multielectrode catheters and duty-cycled radiofrequency energy. J Am Coll Cardiol. 2009. 54:1450–1456.